31 May 2024
CVS Group
plc
("CVS" or
the "Company")
Total Voting Rights
CVS, one of the UK's leading
providers of integrated veterinary services, confirms that no
employees exercised options during May under the CVS Group SAYE
Plans.
The Company therefore continues to
have a total issued share capital of 71,721,269 Ordinary Shares,
each carrying one voting right. The Company holds no Ordinary
Shares in treasury and the total number of voting rights is
therefore 71,721,269.
This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest, in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
Contacts:
CVS
Group
plc
via Camarco
Richard Fairman, CEO
Scott Morrison, Company
Secretary
Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel /
Andrew Clark / Lalit Bose
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran
Walsh / Milo Bonser
Camarco (Financial
PR)
Geoffrey
Pelham-Lane
+44 (0)7733 124
226
Ginny
Pulbrook
+44
(0)7961 315
138
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed
provider of veterinary services with operations in the UK and
Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and
dedicated clinical teams and support colleagues at the core of its
strategy.
The Group operates c.460 veterinary
practices across its two territories, including specialist referral
hospitals and dedicated out-of-hours sites. Alongside the core
Veterinary Practices division, CVS operates Laboratories (providing
diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and
third-party practices) and an online retail business ("Animed
Direct").
The Group employs c.9,000 personnel,
including c.2,400 veterinary surgeons and c.3,400
nurses.